|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cryptocurrency News Articles
With Bullish Momentum, Cardano (ADA) Has Made Noticeable Progress During 2025
Mar 07, 2025 at 07:23 pm
Cardano's price action in 2025 seems to be fueled by positive news surrounding the potential launch of the ADA ETF, whale accumulation

In the ever-evolving cryptocurrency landscape, investors are constantly seeking out promising tokens that hold the potential for exponential growth. While Cardano (ADA) has shown remarkable progress with its bullish momentum, another token might deliver even greater gains in the coming year.
Cardano has undoubtedly made significant strides in 2025, piquing the interest of investors. As the renowned coin continues its journey, analysts anticipate it might return to its all-time high (ATH) of $3. This would translate into an approximately 288% increase from the current price of around $0.7726.
However, Rexas Finance (RXS), an asset tokenization platform currently in the final presale stage, could yield more substantial returns.
Cardano's Growth Potential: Risks Versus Rewards
At the beginning of the year, many crypto analysts set a price target of $3 for Cardano by the end of 2025. This prediction is based on the positive news surrounding the potential launch of the ADA ETF, whale accumulation, and recent ecosystem upgrades like the Leios protocol, which are set to increase scalability and transaction speeds, enabling ADA to surge in price in the long term.
Moreover, analysts believe that in the next few months, ADA could reach $2.50, and by the end of the year, $3 wouldn’t be too out of reach.
Should ADA succeed, an investment of $300 at the current price of $0.7726 would earn 388 ADA tokens. If the target price of $3 is met, the investment would be worth $1,164. This is a 288% increase, which may seem significant, but it is inadequate from a potential perspective.
Rexas Finance (RXS): Set for Exponential Growth
Rexas Finance (RXS) is attempting to become a leader in real-world asset tokenization with a cutting-edge approach to game venture and property investing. Its presale offering recently entered Stage 12 at $0.20 and will start trading at $0.25 on June 19, 2025.
Rexas Finance’s target price for the next year is $6, implying a return on investment of close to 2,900% within 12 months. An investor wagering $300 at a presale price of $0.20 receives 1,500 RXS tokens, which accumulate to $9,000 at the end of the period. This value is during a bull market with a 30x return within a year.
Why Rexas Finance Could Outperform Cardano
According to forecasts by Benzinga, the asset tokenization market will surpass $16 trillion by 2030.
Therefore, Rexas Finance is aggressively pursuing marketing and building an ecosystem, while Cardano is only beginning to catch up and shift its focus to smart contracts, DAOs, and other DApps.
Thus far, RXS has raised $46.3 million by selling 451.5 million tokens. The presale has reached a completion stage of 90.31%, and demand continues to be high as the project approaches its listing on exchanges at $0.25. The funding and early-stage usage of the asset demonstrate strong potential post-listing performance, as opposed to ADA, which has already matured as a top 10 crypto asset.
On June 19, 2025, RXS will be listed on major exchanges, beginning at $0.25. The company has also undergone a Certik security audit, which should inspire greater confidence from investors.
With increasing institutional interest in asset tokenization, RXS will likely experience an increase in demand, propelling the price well past $1 in the following months.
When Cardano moves from $0.7726 to $3, it prepares for a 288% return. On the contrary, RXS is projected to rise from $0.20 to $6, providing a 2,900% return, 10 times greater than the increase Cardano would experience.
Conclusion: RXS Offers a Better Investment Opportunity
Although Cardano has continued to perform well within the blockchain industry, its growth opportunities are minimal compared to the enormous opportunities available in asset tokenization.
Investors expecting large returns on investment will find that RXS offers much more value than ADA.
Disclaimer:info@kdj.com
The information provided is not trading advice. kdj.com does not assume any responsibility for any investments made based on the information provided in this article. Cryptocurrencies are highly volatile and it is highly recommended that you invest with caution after thorough research!
If you believe that the content used on this website infringes your copyright, please contact us immediately (info@kdj.com) and we will delete it promptly.
-
- James Wynn's Leveraged Trading: A New York Minute in Crypto Liquidations
- Nov 20, 2026 at 08:05 pm
- Crypto markets see $2 billion in liquidations, highlighting the volatile nature of leveraged trading and placing notorious trader James Wynn's recent five liquidations into stark relief amidst a wider market correction.
-
- Bybit, Anthropic, and the Shifting Sands of Stock Trading: A New York Minute on Wall Street's Digital Frontier
- Nov 20, 2026 at 12:05 pm
- Bybit is expanding its U.S.-listed stock offerings with Anthropic, as the broader landscape of stock trading grapples with regulatory scrutiny on tokenization and the persistent challenge of illicit financial flows.
-
-
-
-
-
- Navigating Geopolitical Storms: Portfolio Resilience, Wealth Preservation, and the Shifting Sands of Access
- Nov 19, 2026 at 11:55 am
- In an era of escalating geopolitical risks, safeguarding wealth isn't just about asset value—it's about maintaining access. Investors are prioritizing portfolio resilience, liquidity, and diversification across jurisdictions to weather potential disruptions.
-
-

































